Rheumatoid Arthritis

You have full text access to this OnlineOpen article

Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti–tumor necrosis factor α therapy: Is there a need for more comprehensive screening procedures?

  1. Carlotta Nannini1,*,
  2. Fabrizio Cantini1,
  3. Laura Niccoli1,
  4. Emanuele CassarÀ1,
  5. Carlo Salvarani2,
  6. Ignazio Olivieri3,
  7. Edward V. Lally4

Article first published online: 28 MAY 2009

DOI: 10.1002/art.24506

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 61, Issue 6, pages 801–812, 15 June 2009

Additional Information

How to Cite

Nannini, C., Cantini, F., Niccoli, L., CassarÀ, E., Salvarani, C., Olivieri, I. and Lally, E. V. (2009), Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti–tumor necrosis factor α therapy: Is there a need for more comprehensive screening procedures?. Arthritis & Rheumatism, 61: 801–812. doi: 10.1002/art.24506

Author Information

  1. 1

    Hospital Misericordia e Dolce, Prato, Italy

  2. 2

    Hospital S. Maria Nuova, Reggio Emilia, Italy

  3. 3

    Hospital S. Carlo, Potenza, and Hospital Madonna delle Grazie, Matera, Italy

  4. 4

    Rhode Island Hospital, Providence

*2nd Division of Medicine, Rheumatology Unit, Hospital Misericordia e Dolce, Prato, Piazza Ospedale, 1-59100, Prato, Italy

Publication History

  1. Issue published online: 28 MAY 2009
  2. Article first published online: 28 MAY 2009
  3. Manuscript Accepted: 19 FEB 2009
  4. Manuscript Received: 20 NOV 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (109K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Gabriella Nagy, Katalin Lukács, Ágnes Sziray, Katalin Fazekas, Ágnes Florián, László Tamási, Zsuzsánna Károlyi, Biológiai terápia során észlelt mellékhatások – különös tekintettel a bőrgyógyászati szövődményekre, Orvosi Hetilap, 2011, 152, 6, 212

    CrossRef

  2. 2
    Clément Prati, Pascal Claudepierre, Thao Pham, Daniel Wendling, Mortalité dans la spondylarthrite, Revue du Rhumatisme, 2011, 78, 4, 324

    CrossRef

  3. 3
    Clément Prati, Pascal Claudepierre, Thao Pham, Daniel Wendling, Mortality in spondylarthritis, Joint Bone Spine, 2011, 78, 5, 466

    CrossRef

  4. 4
    Thao Pham, Hervé Bachelez, Jean-Marie Berthelot, Jacques Blacher, Yoram Bouhnik, Pascal Claudepierre, Arnaud Constantin, Bruno Fautrel, Philippe Gaudin, Vincent Goëb, Laure Gossec, Philippe Goupille, Séverine Guillaume-Czitrom, Eric Hachulla, Isabelle Huet, Denis Jullien, Odile Launay, Marc Lemann, Jean-Francis Maillefert, Jean-Pierre Marolleau, Valérie Martinez, Charles Masson, Jacques Morel, Luc Mouthon, Stanislas Pol, Xavier Puéchal, Pascal Richette, Alain Saraux, Thierry Schaeverbeke, Martin Soubrier, Anne Sudre, Tu-Anh Tran, Manuelle Viguier, Olivier Vittecoq, Daniel Wendling, Xavier Mariette, Jean Sibilia, TNF alpha antagonist therapy and safety monitoring, Joint Bone Spine, 2011, 78, 15

    CrossRef

  5. 5
    Marta Ferran Farrés, Ramon M. Pujol Vallverdú, Tratamiento de la psoriasis moderada-grave, Piel, 2010, 25, 3, 161

    CrossRef

  6. 6
    Eric L. Matteson, Comorbidities: Should cancer screening be routine in rheumatoid arthritis?, Nature Reviews Rheumatology, 2009, 5, 9, 474

    CrossRef

View Full Article (HTML) Get PDF (109K)